Supplementary Figures S1-6 from Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts

Supplementary figure S1: Survival analysis (Kaplan-Meier estimates) with Breast cancer specific survival (BCSS) as end point for All patients of Cohort 1. Supplementary figure S2: Flowchart showing simplified results from Cohort 1. Supplementary figure S3: Additional prognostic value of gene expression signatures beyond Ki67/IHC, Cohort 1. Supplementary figure S4: Additional prognostic value of Ki67/IHC beyond gene expression signatures, Cohort 1. Supplementary figure S5: Additional prognostic value of gene expression signatures beyond Ki67/IHC, Cohort 2. Supplementary figure S6: Additional prognostic value of Ki67/IHC beyond gene expression signatures, Cohort 2.